On July 9, Jiang Haiming, Member of the Party Leadership Group and Deputy Director of Yantai Municipal Health Commission, led a research team to pay a special visit to Royal Lee Cancer Hospital Guangzhou under the overall coordination of Guangzhou Municipal Health Commission, to conduct in-depth inspection and research on foreign-related medical services and international hospital operation. This research activity is not only a comprehensive review of our hospital’s years of dedication to international medical services, but also fully demonstrates that our achievements in international development have attracted extensive attention and high recognition from an increasing number of government departments and industry peers.

YEO KIM SECK, Chief Executive Officer of Royal Lee Cancer Hospital Guangzhou, and Ma Lanying, Vice President and Director of International Medical Department, gave a warm reception throughout the visit and accompanied the research team to conduct on-site tours of core areas including the International Medical Center, Precision Oncology Diagnosis and Treatment Center and advanced medical equipment zones. The team experienced our standardized diagnosis and treatment workflows, refined service management system, world-leading hardware facilities and efficient and smooth international clinical operation model in an immersive manner.

CEO YEO KIM SECK elaborated on the hospital’s development philosophy of "patient-centered, benchmarked against international standards". Vice President Ma Lanying presented our innovative practices in cross-border medical services. From visa coordination and full-process multilingual medical accompaniment, to direct settlement with more than 40 global commercial insurance providers and international remote consultations, the hospital has built a seamless service chain covering over 30 countries and regions.

The research team paid special attention to our cutting-edge research in oncology diagnosis and treatment technologies. As an early tertiary specialized cancer hospital certified by JCI, we have accumulated rich experience in technologies including Yttrium-90 microsphere therapy, minimally invasive ablation, gene therapy and the clinical application of innovative medicines.

The research team commented: "Royal Lee Cancer Hospital Guangzhou boasts first-class hardware and technologies, and has formed differentiated advantages in the soft power of cross-border medical services. Its international development philosophy and mature operation model provide an extremely valuable practical model for Yantai to advance foreign-related medical services." All members of the team agreed that our professional, standardized and international development path as well as distinctive development positioning carry important exemplary significance for the whole industry.

It is noteworthy that this visit by Yantai Municipal Health Commission marks another important foreign exchange research activity, following multiple batches of visits and exchanges from domestic and foreign government agencies, consulates and medical counterparts. Frequent cross-regional and cross-industry visits continuously validate the international brand influence of our hospital and reflect the growing demand for high-quality international medical services from all sectors of society.

Our hospital has long been committed to building a bridge for medical cooperation between China and foreign countries, deeply integrating international standards with local practices, and striving to build an international medical hub in the Guangdong-Hong Kong-Macao Greater Bay Area and even across the country.

In the future, Royal Lee Cancer Hospital Guangzhou will continue to uphold the spirit of openness and innovation, continuously optimize its international medical service system and expand the global medical cooperation network. With higher-quality diagnosis and treatment technologies and more humanized service experience, we will provide full-cycle, one-stop oncology medical solutions for patients at home and abroad, and contribute Royal Lee’s strength to boosting the high-quality development of international medical services.